![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1873-5576|10|2|210-228
ISSN: 1568-0096
Source: Current Cancer Drug Targets, Vol.10, Iss.2, 2010-03, pp. : 210-228
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Effectiveness of Hsp90 Inhibitors as Anti-Cancer Drugs
Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 10, 2006-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Src inhibitors: drugs for the treatment of osteoporosis, cancer or both?
By Susva M. Missbach M. Green J.
Trends in Pharmacological Sciences, Vol. 21, Iss. 12, 2000-12 ,pp. :